// App-Quantinova.ai

1026 : PEG-LPrA2 is a non-toxic adjuvant for triple negative breast cancer

Researchers

Presenter

  • Courtney D. Dill

Principal Investigators

  • Adriana Harbuzariu

  • Antonio Rampoldi

  • Crystal C. Lipsey

  • Viola Lanier

  • Tia Harmon

  • Danielle Daley-Brown

  • Cynthia Tchio

  • Pierre Candelaria

  • Ruben Rene Gonzalez-Perez

Medical Centers

  • Morehouse School of Medicine, Atlanta, GA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Obesity

  • Solid malignancies

Biomarkers

  • Leptin receptor

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved